Skip to main content

Advertisement

Table 1 Characteristics of 17 patients with combined anti-GBM disease and membranous nephropathy.

From: Anti-glomerular basement membrane disease superimposed on membranous nephropathy: a case report and review of the literature

Case Number [ref #] Age/Sex Initial serum creatinine (mg/dL) Clinical presentation Treatment Outcome
1 [2] 49/M 18.0 Edema Steroids Died
2 [3] 53/M 13.0 Edema Steroids, azathioprine Hemodialysis
3 [3] 44/M 3.1 Edema Steroids Hemodialysis
4 [4] 20/F 1.2 Cough, syncope None Survived
5 [5] 19/F 10.5 Hemoptysis Steroids (p)*, azathioprine, nephrectomy Hemodialysis
6 [6] 25/M 2.1 Hemoptysis Steroids, PP** Died
7 [7] 65/M 4.0 Edema Steroids, PP, cyclophosphamide Died
8 [8] 20/M 3.0 Fever, sore throat, lumbar pain Steroids, PP Survived
9 [9] 54/M 1.1 Cough, arthralgia Steroids, PP Hemodialysis
10 [10] 60/M 19.5 Fatigue, anorexia, edema Steroids (p), PP Hemodialysis
11 [11] 57/not reported 11.8 Fatigue, hemoptysis Steroids (p), PP, cyclophosphamide Hemodialysis
12 [12] 50/M 0.7 Edema Steroids (p), PP, cyclophosphamide Survived
13 [13] 50/F 8.9 Edema, nausea Steroids (p), PP Hemodialysis
14 [14] 54/F 8.9 Hematuria Steroids, PP Hemodialysis
15 [15] 49/M 7.3 Hematuria, flank pain, fatigue Steroids, PP, cyclophosphamide Hemodialysis
16 [16] 50/F 11.6 Edema Steroids, PP, cyclophosphamide Hemodialysis
17 (present case) 59/M 25.0 Fatigue, oliguria, nausea Steroids, PP, cyclophosphamide Hemodialysis
  1. PP, plasmapheresis; p, pulse steroid therapy